Guideline for anti-TNF-α therapy in psoriatic arthritis

被引：105

作者：

Kyle, S

Chandler, D

Griffiths, CEM

Helliwell, P

Lewis, J

McInnes, I

Oliver, S

Symmons, D

McHugh, N

机构：

[1] Royal Natl Hosp Rheumat Dis, Bath BA1 IRL, Avon, England

[2] Board Trustees & Managment Comm, Psoriatr Arthopathy Alliance, Manchester, Lancs, England

[3] Salford Royal Hosp NHS Trust, Manchester, Lancs, England

[4] Univ Leeds, Leeds, W Yorkshire, England

[5] Glasgow Royal Infirm, Ctr Rheumat Dis, Glasgow G4 0SF, Lanark, Scotland

[6] Univ Manchester, RCN Rheumatol Steering Comm, Manchester, Lancs, England

[7] Univ Manchester, E Cheschire NHS Trust & ARC Epidemiol Unit, Manchester, Lancs, England

来源：

RHEUMATOLOGY | 2005年 / 44卷 / 03期

关键词：

D O I：

10.1093/rheumatology/keh514

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：390 / 397

页数：8

共 41 条

[1] How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH [J].

Anker, SD ;

Coats, AJS .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2002, 86 (2-3) :123-130

[2]

[Anonymous], BR J RHEUMATOL, DOI DOI 10.1093/RHEUMAT0L0GY/30.4.245

[3]

Antoni C, 2002, ARTHRITIS RHEUM-US, V46, pS381

[4] Open-label study of infliximab treatment for psoriatic arthritis: Clinical and magnetic resonance imaging measurements of reduction of inflammation [J].

Antoni, C ;

Dechant, C ;

Lorenz, PDHM ;

Wendler, J ;

Ogilvie, A ;

Lueftl, M ;

Kalden-Nemeth, D ;

Kalden, JR ;

Manger, B .

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2002, 47 (05) :506-512

[5] Treatment of psoriatic arthritis and psoriasis vulgaris with the tumor necrosis factor inhibitor infliximab [J].

Cauza, E ;

Spak, M ;

Cauza, K ;

Hanusch-Enserer, U ;

Dunky, A ;

Wagner, E .

RHEUMATOLOGY INTERNATIONAL, 2002, 22 (06) :227-232

[6] Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial [J].

Chaudhari, U ;

Romano, P ;

Mulcahy, LD ;

Dooley, LT ;

Baker, DG ;

Gottlieb, AB .

LANCET, 2001, 357 (9271) :1842-1847

[7] Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure -: Results of the Anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial [J].

Chung, ES ;

Packer, M ;

Lo, KH ;

Fasanmade, AA ;

Willerson, JT .

CIRCULATION, 2003, 107 (25) :3133-3140

[8] Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis - A Department of Veterans Affairs cooperative study [J].

Clegg, DO ;

Reda, DJ ;

Mejias, E ;

Cannon, GW ;

Weisman, MH ;

Taylor, T ;

BudimanMak, E ;

Blackburn, WD ;

Vasey, FB ;

Mahowald, ML ;

Cush, JJ ;

Schumacher, HR ;

Silverman, SL ;

Alepa, FP ;

Luggen, ME ;

Cohen, MR ;

Makkena, R ;

Haakenson, CM ;

Ward, RH ;

Manaster, BJ ;

Anderson, RJ ;

Ward, JR ;

Henderson, WG .

ARTHRITIS AND RHEUMATISM, 1996, 39 (12) :2013-2020

[9] Leflunomide decreases joint erosions and induces reparative changes in a patient with psoriatic arthritis [J].

Cuchacovich, M ;

Soto, L .

ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (10) :942-943

[10] Treatment of refractory psoriatic arthritis with infliximab: a 12 month observational study of 16 patients [J].

Feletar, M ;

Brockbank, JE ;

Schentag, CT ;

Lapp, V ;

Gladman, DD .

ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (02) :156-161

← 1 2 3 4 5 →